US Stock MarketDetailed Quotes
BPTH Bio-Path Holdings
- 2.760
- -0.240-8.00%
Close May 8 16:00 ET
- 2.800
- +0.040+1.45%
Post 19:47 ET
4.32MMarket Cap-82P/E (TTM)
2.970High2.690Low71.42KVolume2.950Open3.000Pre Close201.50KTurnover4.57%Turnover RatioLossP/E (Static)1.57MShares44.80052wk High9.79P/B4.31MFloat Cap2.35052wk Low--Dividend TTM1.56MShs Float23999.988Historical High--Div YieldTTM9.33%Amplitude2.350Historical Low2.821Avg Price1Lot Size
About Bio-Path Holdings Company
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
Company Profile
SymbolBPTH
Company NameBio-Path Holdings
Listing DateMar 10, 2014
Issue Price0.50
Founded2007
CEOMr. Peter H. Nielsen
MarketNASDAQ
Employees10
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4710 Bellaire Boulevard,Suite 210
CityBellaire
ProvinceTexas
CountryUnited States of America
Zip Code77401
Phone1-832-742-1357
Company Executives
- Name
- Position
- Salary
- Peter H. Nielsen
- Chairman of the Board, Chief Executive Officer, President, Principal Accounting Officer, Chief Financial Officer and Treasurer
- 1.01M
- Douglas P. Morris
- Director, Secretary and Director, Investor Relations
- 110.68K
- Paul D. Aubert
- Independent Director
- 94.93K
- Heath W. Cleaver, C.P.A.
- Independent Director
- 106.43K
- Aline B. Sherwood
- Independent Director
- 66.10K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
